BK Channel Antagonists: Use of for Seizure Prevention; paxilline
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 08/27/2019
Pipeline Type
New Drugs in Development
Phase Of Development
Preclinical
Sponsors and Collaborators
Carnegie Mellon University, Epilepsy Foundation (EF), Milken Family Foundation (MFF)
Mechanism of Action
Ion Channel
Mechanism Description
Potassium Channel Blocker
Populations Tested In
N/A
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - NTCG 2005
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link